GE Healthcare Life Sciences inks R&D partnership
Photo | Matt Wright
GE Healthcare Life Sciences' Marlborough office
Marlborough-based GE Healthcare Life Sciences has signed a research and development and distribution partnership with a Kentucky health software and equipment company with a goal of personalizing tissue regeneration.
The partnership will combine products of both of the companies: GE's IN Cell Analyzer, an imaging platform, and Advanced Solutions Life Sciences' BioAssemblyBot, which can print manufactured tissue in three dimensions.
Biopharmaceutical companies today test their drugs in two-dimension models, the companies said. But precise 3D models provide a more physiologically relevant environment for drug testing because they mimic human reactions.
Bioprinted tissues are small in size and die quickly, due to an inability to engineer small blood vessels, the companies said. Advanced Solutions Life Sciences' technology allows bioprinted microvessels to develop in a way they can deliver nutrients, oxygen, and hormones to the 3D tissue model and remove waste. The partnership, the firms said, would allow life scientists and tissue engineers to quickly create living 3D tissues.
The partnership was announced Sunday to coincide with a joint meeting of the American Society of American Cell Biology and the European Molecular Biology Organization in Washington, D.C. this week.
Advanced Solutions Life Sciences opened its first New England location in June 2018 with an office in Manchester, N.H.
WBJ Web Partners
Most Recent
Most Recent
0 Comments